Tilray Brands is trading at $3.36, down 5.07%, as coverage linked selling pressure to lower cannabis net revenue.

  • Quarterly cannabis net revenue fell to $56.1 million from $64.5 million a year earlier, despite record total revenue; coverage also cited revenue below analyst expectations.
  • Tilray reaffirmed fiscal 2027 adjusted EBITDA guidance of $68 million to $75 million.
  • Wider markets were mixed, with no broad-market drop matching this move.